(MENAFN- GlobeNewsWire - Nasdaq) Key market opportunities for Cas12 proteins include rising government investments in biotech, increased demand for diagnostics in developing regions, growing integration into sequencing platforms, gene-editing advancements, and expanding applications in personalized medicine and agricultural biotechnology.

Dublin, Nov. 04, 2025 (GLOBE NEWSWIRE) -- The "Cas12 Protein Market Report 2025" has been added to ResearchAndMarkets's offering.

The Cas12 Protein Global Market Report 2025 offers essential insights for strategists, marketers, and senior management to assess this rapidly expanding market. This comprehensive analysis provides a roadmap of emerging trends expected to shape the market over the next decade and beyond, relevant for those aiming to capitalize on this growth sector.

The Cas12 protein market's landscape has been evolving rapidly, demonstrating significant growth. Projections indicate a rise from $1.95 billion in 2024 to $2.26 billion in 2025, with a robust CAGR of 15.9%. This growth is underpinned by increased government investments in biotechnology, a surge in demand for diagnostic solutions in developing regions, integration with next-gen sequencing platforms, and advancements in protein engineering techniques enhancing Cas12 specificity.

Forecasts further reveal the Cas12 protein market expanding to $4.03 billion by 2029, maintaining a CAGR of 15.5%. Factors driving this include the prevalence of genetic disorders, escalated gene-editing R&D investments, heightened awareness of personalized medicine, and the rising utility of Cas12 proteins in agricultural biotech. Notable trends in this period encompass integration with other CRISPR components and advancements in gene-editing delivery technologies.

Genetic diseases are a significant growth driver for the Cas12 protein market. The increasing rate of consanguineous marriages correlates with a rise in genetic disorders, accentuating the need for precise gene therapies facilitated by Cas12 proteins. For instance, the UK's National Health Service reported around 17,000 individuals in England living with sickle cell disease, indicating a potent market driver.

Strategic moves by key market players are fuelling advancements. Regeneron Pharmaceuticals, Inc.'s $100 million investment in Mammoth Biosciences highlights this trend. The collaboration combines innovative CRISPR enzymes with advanced gene-editing delivery systems, promoting next-gen genetic medicines.

In a parallel move, Hui-Gene Therapeutics Co., Ltd. has joined forces with Kactus Biotechnology to expedite gene-editing therapies for rare disorders. This strategic alliance aims to leverage expertise to propel genome medicines forward in Greater China, targeting commercialization and GMP manufacturing.

Leading companies in the Cas12 protein market include Thermo Fisher Scientific Inc., Bio-Techne Corporation, and Integrated DNA Technologies Inc., among others. The market's geographic dynamics depict North America as the largest region in 2024, with Asia-Pacific projected to be the fastest-growing. However, the market faces challenges due to global trade tensions and tariff fluctuations, notably impacting pharmaceutical companies reliant on specific inputs. The industry's response includes expanding API production in regions like India and Europe and advocating for trade exemptions.

The Cas12 protein market research provides comprehensive insights, offering data on global market size, regional shares, and detailed segments. This report serves as a crucial resource for stakeholders seeking an in-depth understanding of current and future industry landscapes. Cas12 proteins are pivotal in the realms of molecular diagnostics and therapeutic development, used extensively across academic institutions, biotech firms, and diagnostic labs. The market thrives on sales of diagnostic kits, research reagents, and biosensors.

The market's valuation is a reflection of the transactions within, offering a wide lens on revenue streams generated through product sales and related services in specified geographies.

Key Attributes:

Report Attribute	Details
No. of Pages	250
Forecast Period	2025 - 2029
Estimated Market Value (USD) in 2025	$2.26 Billion
Forecasted Market Value (USD) by 2029	$4.03 Billion
Compound Annual Growth Rate	15.5%
Regions Covered	Global

Reasons to Purchase:

• Acquire a global viewpoint with extensive coverage across 15 key geographies.
• Evaluate the influence of significant macro factors, including geopolitical conflicts, trade policies, tariffs, and post-pandemic supply chain adjustments.
• Develop targeted regional and country strategies using localized data analyses.
• Identify and strategize around growth segments for potential investment.
• Gain a competitive edge by leveraging forecast data, drivers, and emerging market trends.
• Comprehend consumer profiles through current market share analyses.
• Benchmark organizational performance against top competitors.
• Utilize reliable data and analysis for robust presentations and reports.
• Receive regular updates with the latest data, accompanied by an Excel data sheet for streamlined extraction and analysis.
• Benefit from an Excel dashboard for enhanced data accessibility.

Scope:

• By Type: Natural and Modified Cas12 Proteins, CRISPR Component Integration
• By Formulation: Liquid, Lyophilized Powder, Plasmid-Derived
• By Delivery Method: Viral Vectors, Lipid Nanoparticles, Electroporation, Microinjection
• By Application: Genome Editing, Gene Knockout, Genetic Engineering, Therapeutics Development
• By End User: Academic Research Institutes, Pharma and Biotech Companies, Diagnostic Labs, Agricultural Firms

Companies Featured

• Thermo Fisher Scientific Inc.
• Bio-Techne Corporation
• Integrated DNA Technologies Inc.
• GenScript Biotech Corporation
• Takara Bio Inc.
• Abcam plc
• Aldevron LLC
• New England Biolabs Inc.
• Cusabio Biotech Co. Ltd.
• Synthego Corporation
• ABclonal Technology Co. Ltd.
• Mammoth Biosciences Inc.
• Rockland Immunochemicals Inc.
• Creative BioMart
• Editas Medicine Inc.
• VectorBuilder
• Sherlock Biosciences
• Biomatik
• SBS Genetech Co. Ltd.
• ProSpec-Tany Technogene Ltd.
• Inscripta Inc.
• Addgene Inc.

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

• Cas12 Protein Market

CONTACT: CONTACT: Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN04112025004107003653ID1110293547